REFERENCES
- Andrew M, Michelson AD, Bovill T, et al. The prevention and treatment of thromboembolic disease in children: a need for thrombophilia programs. Pediatr Henzatol OncoL 1997;197:7–22.
- Sutor AH, Uhl M. Diagnosis of thromboembolic disease during infancy and childhood. Semin Thromb Hemost. 1997;23:237–245.
- Selhub J, D'Angelo A. Hyperhomocysteinemia and thrombosis: acquired conditions. Thromb Haemost. 1997;78:527–531.
- Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost. 1997;78:523–526.
- Massicotte P, Adams M, Marzinotto V, et al. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr. 1996;128:313–318.
- Leaker M, Massicotte MP, Brooker LA, et al. Thrombolytic therapy in pediatric patients: a comprehen-sive review of the literature. Thromb Haemost. 1996;76:132–134.
- Dix D, Marzinotto V, Leaker M, et al. The use of low molecular weight heparin in pediatric patients: review of a single institution experience [abstract]. Am Pediatr Soc. 1998.
- Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ. 1998;316:894–898.
- Roy M, Schmidt B. Neonatal thrombosis: are we doing the right studies? Semin Throm Hemost. 1995;21: 313-316.